Early immune events in scleroderma.
A number of humoral and cellular immune abnormalities are present in patients with early scleroderma (systemic sclerosis). Most of these abnormalities reflect ongoing autoimmune reactions of the cellular and humoral types, resulting in a variety of autoantibodies to cellular and tissue constituents. Evidence exists for a defect(s) in immunoregulation favoring excessive helper T-cell activity. The presence of circulating cytokines and shed interleukin-2 receptors suggest ongoing cellular immune reactions are occurring, generating cytokines and lymphokines that are capable of effecting the vascular and fibrotic lesions that are hallmarks of the disease. Future directions for research are suggested that would focus on determining if, and at what point, fibroblasts might function autonomously to generate excessive matrix components and on determining the nature of the original antigenic stimulus that starts the scleroderma process.
Postlethwaite
A E
AE
University of Tennessee, Memphis.
D000917:Antibody Formation / Q000502:physiology; D003240:Connective Tissue Diseases / Q000209:etiology / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology; D012595:Scleroderma, Systemic / Q000150:complications / Q000276:immunology*; D014652:Vascular Diseases / Q000209:etiology / Q000276:immunology